Serge Sablé
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
Papers in
-
- Cancer therapeutics and mechanisms 3
- Signaling Pathways in Disease 2
-
- Synthetic Organic Chemistry Methods 3
- Asymmetric Synthesis and Catalysis 2
- Oxidative Organic Chemistry Reactions 2
- Co-authors
- Marc Vuilhorgne (5 shared papers)Jean‐François Riou (1 shared paper)Laurent P. Rivory (1 shared paper)Jacques Robert (1 shared paper)Susan M. Pond (1 shared paper)Marie‐Christine Haaz (1 shared paper)Alain Commerçon (1 shared paper)Cécile Gaillard (1 shared paper)
In The Last Decade
Serge Sablé
13 papers receiving 341 citations
Peers
Comparison fields: 5 of 59
- Biomaterials 58
- Oncology 106
- Organic Chemistry 116
- Pharmacology 29
- Toxicology 11
Countries citing papers authored by Serge Sablé
This map shows the geographic impact of Serge Sablé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Sablé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Sablé more than expected).
Fields of papers citing papers by Serge Sablé
This network shows the impact of papers produced by Serge Sablé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Sablé. The network helps show where Serge Sablé may publish in the future.
Co-authors
The 25 scholars most cited alongside Serge Sablé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients. | 1996 | 116 |
| 2 | 2013 | 57 | |
| 3 | 2012 | 49 | |
| 4 | 2010 | 32 | |
| 5 | 1994 | 26 | |
| 6 | 2021 | 20 | |
| 7 | 2003 | 15 | |
| 8 | 2003 | 13 | |
| 9 | 1997 | 8 | |
| 10 | 1999 | 8 | |
| 11 | 2019 | 6 | |
| 12 | 2004 | 3 | |
| 13 | 1993 | 2 |
About Serge Sablé
Serge Sablé is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Oncology and Biotechnology, having authored 13 papers that have together received 355 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (3 papers), Synthetic Organic Chemistry Methods (3 papers), Asymmetric Synthesis and Catalysis (2 papers), Signaling Pathways in Disease (2 papers), Oxidative Organic Chemistry Reactions (2 papers), Marine Sponges and Natural Products (2 papers), Microbial Natural Products and Biosynthesis (2 papers) and Traditional and Medicinal Uses of Annonaceae (1 paper). The work is most often cited by research in Biomaterials (58 citations), Oncology (106 citations), Organic Chemistry (116 citations), Pharmacology (29 citations) and Toxicology (11 citations). Serge Sablé has collaborated with scholars based in France, Germany and Malaysia. Frequent co-authors include Marc Vuilhorgne, Jean‐François Riou, Laurent P. Rivory, Jacques Robert, Susan M. Pond, Marie‐Christine Haaz, Alain Commerçon, Cécile Gaillard, Janine Cossy and Amandine Guérinot. Their work appears in journals such as Tetrahedron Letters, Chemistry - A European Journal, Synlett, The Journal of Organic Chemistry and Biomacromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.